Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee

ClinicalTrials.gov ID: NCT02847702

Public ClinicalTrials.gov record NCT02847702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 10:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multicenter, Randomized, Double-blind, Placebo Controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of VM902A in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Study identification

NCT ID
NCT02847702
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

  • VM902A 200-mg Capsules Drug
  • VM902A 400-mg Capsules Drug
  • Naproxen 500-mg Capsules Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2016
Primary completion
Nov 21, 2016
Completion
Nov 21, 2016
Last update posted
Nov 21, 2017

2016

United States locations

U.S. sites
31
U.S. states
12
U.S. cities
31
Facility City State ZIP Site status
Investigational Site Birmingham Alabama 35216
Investigational Site Huntsville Alabama 35801
Investigational Site DeLand Florida 32720
Investigational Site Hialeah Florida 33012
Investigational Site Homestead Florida 33030
Investigational Site Jupiter Florida 33458
Investigational Site Orlando Florida 32806
Investigational Site Port Orange Florida 32129
Investigational Site Port Saint Lucie Florida 34952
Investigational Site The Villages Florida 32162
Investigational Site West Palm Beach Florida 33409
Investigational Site Columbus Georgia 31904
Investigational Site Avon Indiana 46123
Investigational Site Muncie Indiana 47304
Investigational Site Newton Kansas 67114
Investigational Site Prairie Village Kansas 66206
Investigational Site New Bedford Massachusetts 02740
Investigational Site Bay City Michigan 48706
Investigational Site Troy Michigan 48098
Investigational Site Kansas City Missouri 64114
Investigational Site St Louis Missouri 63141
Investigational Site Hartsdale New York 10530
Investigational Site Rosedale New York 11422
Investigational Site The Bronx New York 10467
Investigational Site Cincinnati Ohio 45219
Investigational Site Dayton Ohio 45417
Investigational Site Dublin Ohio 43016
Investigational Site Duncansville Pennsylvania 16635
Investigational Site Ogden Utah 84405
Investigational Site Salt Lake City Utah 84121
Investigational Site South Jordan Utah 84095

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02847702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 21, 2017 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02847702 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →